Spacelabs introduces vital signs monitor

Spacelabs Healthcare has released Ultraview DM3, which provides caregivers with a dual-mode technology for measuring vital signs (SpO2, pulse rate, non-invasive blood pressure, respiration and temperature) on adult and pediatric patients.

The latest in the Ultraview series, the new DM3 can be used in patient care settings which require basic vital signs monitoring, according to the Issaquah, Wash.-based company. In spot-check mode, the DM3 supports batch collection of basic vitals, including supplemental patient information, such as pain level, patient position, site check and caregiver ID.

After collection of patient vitals has been completed, the DM3 can be connected to the network to transmit the spot-check records for one or multiple patients to the hospital’s EMR system, Spacelabs said.

In monitoring mode, the company said its DM3 provides continuous monitoring and alarm support for patients who require more vigilance.

Around the web

The American College of Cardiology has shared its perspective on new CMS payment policies, highlighting revenue concerns while providing key details for cardiologists and other cardiology professionals. 

As debate simmers over how best to regulate AI, experts continue to offer guidance on where to start, how to proceed and what to emphasize. A new resource models its recommendations on what its authors call the “SETO Loop.”

FDA Commissioner Robert Califf, MD, said the clinical community needs to combat health misinformation at a grassroots level. He warned that patients are immersed in a "sea of misinformation without a compass."

Trimed Popup
Trimed Popup